Her first postdoctoral position was a Junior Research Fellowship at
Christ Church, University of Oxford to develop mathematical and computational models that describe biomechanical and biochemical stimulation of tissues. She also held two concurrent Visiting Research Fellowships at the Centre for Regenerative Medicine, Bath, and Tissue Repair and Engineering Centre, UCL during that time. Her work advancing cancer therapies has been recognised in the national press. Within nervous system tissue engineering, she has developed an interdisciplinary programme spanning bioengineering, computational modelling and tissue engineering to characterise the response of repairing nerves to chemical and mechanical stimuli, and integrate these data to design and test repair constructs. This is complemented by her work using computational modelling to understand the role of biochemical and biophysical stimuli, and define operating parameters, in tissue engineering development. Shipley has been a strong advocate for healthcare engineering and the translation of scientific discoveries into practice, working in particular across UCL and partner hospitals. She co-founded the UCL Centre for Nerve Engineering to bring together engineering and physical sciences with the life and clinical sciences to tackle translational nerve engineering problem. During 2018-2024 she led the UCL Institute of Healthcare Engineering which acts as an interface between engineering, computating and healthcare research at UCL. In March 2020, Shipley co-led the UCL Ventura CPAP program across UCL /
UCL Hospitals NHS Trust /
Mercedes F1. The team reverse engineered and manufactured 10,000 non-invasive ventilators (continuous positive airways pressure devices) and associated devices and consumables which were distributed across the NHS during the
COVID-19 pandemic. The designs and manufacturing instructions was made available globally through an zero cost license with over 2,000 downloads across 105 countries, and the team supported extensive international donations. The devices were used to treat patients in over 30 countries. == Honours, awards and recognition ==